Jobs boom as CBD oil given the green light

CBD oil, derived from cannabis buds, was last week rescheduled by the Therapeutic Goods Administration from class four to three, meaning low-dose CBD products that have been run through clinical trials will be sold over-the-counter as soon as late 2021. Now industries from marijuana growers and wholesalers to packaging companies and pharmacies are anticipating a jobs boom, with the product likely to surge in popularity in a similar way to its boom overseas.CBD oil, which has surpassed vitamin C…



Click here to view the original article.